WG
AMED

Winton Group’s Amedisys AMED Stock Holding History

Winton Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,516
Closed -$294K – 951
2022
Q4 		$294K Sell
3,516
-1,610
-31% -$145K 0.02% 790
2022
Q3 		$496K Buy
+5,126
New +$611K 0.03% 646
2019
Q4 		– Sell
-33,989
Closed -$4.45M – 1529
2019
Q3 		$4.45M Buy
33,989
+28,469
+516% +$3.71M 0.05% 353
2019
Q2 		$670K Buy
5,520
+2,642
+92% +$314K 0.01% 560
2019
Q1 		$355K Sell
2,878
-1,681
-37% -$211K 0.01% 728
2018
Q4 		$534K Sell
4,559
-1,356
-23% -$160K 0.01% 470
2018
Q3 		$739K Buy
5,915
+761
+15% +$84K 0.02% 475
2018
Q2 		$440K Sell
5,154
-1,119
-18% -$82.2K 0.01% 672
2018
Q1 		$379K Buy
+6,273
New +$357K 0.01% 888

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Winton Group's AMED Position: Q1 2023 in Review

Winton Group sold out of Amedisys (AMED) in Q1 2023, closing a stake of 3,516 shares — an estimated $294K sold.

Winton Group first reported a position in AMED in Q1 2018 and held it in 9 quarters. The position peaked at $4.45M in Q3 2019. 281 funds tracked by Wall St. Rank hold AMED as of Q1 2023.

  • Winton Group reported no remaining Amedisys position as of Q1 2023 after selling out during the quarter.
  • Winton Group sold 3,516 Amedisys shares in Q1 2023, an estimated $294K.
  • Winton Group first reported a position in Amedisys in Q1 2018 and held it in 9 quarters.
  • Winton Group's Amedisys position peaked at $4.45M in Q3 2019.
  • 281 funds tracked by Wall St. Rank held Amedisys as of Q1 2023.

Based on Winton Group's 13F filing for Q1 2023, filed 12 May 2023.